IP Library Granted Patent US 7,937,142
Granted Patent B2
US 7,937,142 · App. 12/437,820 · Granted May 3, 2011

Irritation-reducing ocular iontophoresis device

Assignee: EyeGate Pharma S.A.S.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,937,142
App. No.
12/437,820
Granted
May 3, 2011
Kind
B2
Abstract

The invention provides an ocular iontophoresis device for delivering medication, the device comprising a medication reservoir suitable for being positioned on the eye, at least one medication in solution in the reservoir, an active electrode disposed in the reservoir, and a passive electrode, the device including at least one medication dissolved in non-saline water, the said solution having a pH lying in the range 6.5 to 8.5, the medication having a pKa lying in the range about 5.5 to about 9.5 and includes an active principle which is associated with an additive, such as a dendrimer, a polymer, a nanoparticle, a microsphere, a liposome, or an emulsion, and having an ionic form of valency greater than or equal to 1.

Claims (1)

1. An ocular iontophoresis device for delivering medication, the device comprising a medication reservoir suitable for being positioned on the eye, at least one medication in solution in the reservoir, an active electrode disposed in the reservoir, and a passive electrode, the device including at least one medication dissolved in non-saline water, the said solution having a pH lying in the range 6.5 to 8.5, the medication having a pKa lying in the range about 5.5 to about 9.5 and including an active principle which is associated with an additive, such as a dendrimer, a polymer, a nanoparticle, a microsphere, a liposome, or an emulsion, and having an ionic form of valency greater than or equal to 1.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2010
From: ROY, PIERRE
To: OPTIS FRANCE S.A.
Reel/Frame 024441/0260 →
CHANGE OF NAME Recorded May 26, 2010
From: OPTIS FRANCE S.A.
To: EYEGATE PHARMA S.A.
Reel/Frame 024441/0566 →
CHANGE OF LEGAL ENTITY Recorded May 26, 2010
From: EYEGATE PHARMA S.A.
To: EYEGATE PHARMA S.A.S.
Reel/Frame 024444/0140 →
Priority Claims (1)
FR 04 04673 · Apr 30, 2004 · national
Continuity (3)
Continuation 11651150 · Jan 8, 2007
Continuation 10861117 · Jun 3, 2004
Related Publication 20090287139A1 · Nov 19, 2009